Share
Market Research Report

MINIMAL RESIDUAL DISEASE TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TechnologyFlow Cytometry · Polymerase chain reaction (PCR) · and Next generation sequencing
  • By ApplicationLymphoma · Solid Tumors · and Others
  • By End UserHospitals · Clinics · Research Laboratories · and Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East and Africa
  • Published In27 Mar 2026
  • Report CodeCMI6888
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Technology
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Epidemiology
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Minimal Residual Disease Testing Market, By Technology, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Flow Cytometry
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Polymerase chain reaction (PCR)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Minimal Residual Disease Testing Market, By Application, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Lymphoma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Solid Tumors
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Minimal Residual Disease Testing Market, By End User, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Research Laboratories
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Minimal Residual Disease Testing Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Bio-Rad Laboratories, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Guardant Health, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Adaptive Biotechnologies
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Invitae Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ASURAGEN, INC.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Invivoscribe, Inc. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Laboratory Corporation of America Holdings
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Natera, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sysmex Inostics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • FOUNDATION MEDICINE, INC.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sebia
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Myriad Genetics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst View

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact